Relationship between Frontotemporal Dementia and Corticobasal Degeneration/Progressive Supranuclear Palsy

@article{Kertesz2004RelationshipBF,
  title={Relationship between Frontotemporal Dementia and Corticobasal Degeneration/Progressive Supranuclear Palsy},
  author={Andrew Kertesz and David G Munoz},
  journal={Dementia and Geriatric Cognitive Disorders},
  year={2004},
  volume={17},
  pages={282 - 286}
}
  • A. Kertesz, D. Munoz
  • Published 1 June 2004
  • Medicine
  • Dementia and Geriatric Cognitive Disorders
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) were described as separate entities, but prior to that an extrapyramidal variety of Pick’s disease was recognized. Subsequently a pathological overlap between these conditions and clinical overlap between frontotemporal dementia, primary progressive aphasia, corticobasal degeneration syndrome and more recently PSP was recognized. Initially only the movement disorder had been emphasized, but now the behavioral and language… Expand
Chapter 6 Progressive Supranuclear Palsy and Corticobasal Degeneration
Publisher Summary The chapter offers information on progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Although PSP and CBD are considered distinct nosologic entities, it isExpand
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP
TLDR
Frontotemporal lobar degeneration, corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP) have overlapping clinical features, and the prediction of tau-positive pathology from a CBD or PSP-like presentation is good, while the frontotem temporal dementia (FTD)-motor neuron disease syndrome almost certainly predicts motor neuron degeneration. Expand
Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies.
  • K. Frey
  • Medicine
  • Seminars in nuclear medicine
  • 2021
Two pathologically distinct neurodegenerative conditions, progressive supranuclear palsy and corticobasal degeneration, share in common deposits of tau proteins that differ both molecularly andExpand
Frontotemporal Lobar Degeneration
TLDR
In this chapter, focus will be on clinical symptoms, diagnostics including neuropsychological and neuroimaiging findings, and therapy, while the second and third part will highlight recent findings in neurogenetics and neuropathology, respectively. Expand
Progressive Supranuclear Palsy
Publisher Summary Progressive supranuclear palsy (PSP) is an age-dependent neurodegenerative condition, and the clinical progression of PSP has similarities to amyotrophic lateral sclerosis—withExpand
Progressive Supranuclear Palsy: expanding the clinical and genetic spectrum
TLDR
Neuronal and glial tau positive aggregates are predominantly found in basal ganglia and brainstem, and the significant association of PSP with the common H1 tau haplotype likely points to a pathophysiological role of the tau protein in the disease process. Expand
Corticobasal degeneration.
TLDR
The observation that the aggregation of tau, a microtubule-associated protein, is involved in the pathology of several neurologic disorders has revolutionized understanding of CBD and its relationship to other neurodegenerative diseases that are collectively called tauopathies. Expand
Cognitive Impairment in the Lateralized Phenotype of Corticobasal Degeneration
TLDR
In patients with lateralized CBD, the most salient aspects of cognitive impairment were an evident alteration of rapid alternating operative strategies, associated with the evident impairment of set shifting, of executive operations, of operative and sequential procedure and of implementation of judgement and abstract reasoning. Expand
Apathy in corticobasal degeneration: possible parietal involvement.
TLDR
A dedicated study is set out to study behavioral alterations, specifically apathy, and to compare the results obtained with those deriving from a well-defined Parkinson's disease population, arguing for a possible role of the parietal neural networks as a determinant of apathy. Expand
Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy.
TLDR
Investigating awareness of cognitive deficits in FTD, CBD and PSP using a multidimensional approach to assessment found that loss of insight was a feature of each of the three patient groups, and different patterns of neurobiological decline in the separate patient groups predicted insight deficits. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 81 REFERENCES
Clinical and Pathological Overlap between Frontotemporal Dementia, Primary Progressive Aphasia and Corticobasal Degeneration: The Pick Complex
TLDR
The term Pick complex is suggested to indicate that these clinical and pathological variations are related and they were first described by Pick as clinical manifestations of fronotemporal atrophy. Expand
Corticobasal Ganglionic Degeneration and Progressive Supranuclear Palsy Presenting with Cognitive Decline
Corticobasal ganglionic degeneration (CBGD) and progressive supranuclear palsy (PSP) were originally described in the sixties as predominantly motor syndromes. Over the years, the detailed study ofExpand
The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia
TLDR
There is a clinical overlap between CBD, frontotemporal dementia, and primary progressive aphasia and there is also a pathologic overlap between these clinical syndromes. Expand
Corticobasal degeneration presenting with nonfluent primary progressive aphasia: a clinicopathological study
A 62-year-old woman initially presented with slowly progressive nonfluent aphasia with minimal intellectual involvement. Echolalia and personality change were prominent whereas parkinsonian featuresExpand
Corticobasal ganglionic degeneration and/or frontotemporal dementia? A report of two overlap cases and review of literature
TLDR
Evidence is emerging to suggest that the clear distinction drawn between FTD and CBD by the existing viewpoint, needs revision, and it may be better to distinguish between the clinical and pathological levels of description and to classify cases, in vivo, on the basis of the clinical phenotype. Expand
Neuropathologic Overlap of Progressive Supranuclear Palsy, Pick's Disease and Corticobasal Degeneration
TLDR
Despite significant overlap among the three neurodegenerative diseases examined, the morphological and regional differences suggest that each is a distinct pathophysiological entity. Expand
Dementia as the most common presentation of cortical-basal ganglionic degeneration
TLDR
Dementia was the most common presentation of CBGD in this study and despite the best efforts to define criteria to enhance the specificity of a diagnosis, it is becoming clear that the clinical syndrome that accompanies this disease is quite varied. Expand
Progressive Supranuclear Palsy
TLDR
The multiple neurotransmitter abnormalities, including those affecting dopamine, acetylcholine, γ-aminobutyric acid and norepinephrine and pathways, as well as both pre- and post-synaptic pathology, make pharmacological therapy of PSP a challenge. Expand
The pathology and nosology of primary progressive aphasia
TLDR
The concept of “Pick complex” is proposed to include other neurodegenerative diseases characterized by focal cortical degeneration, such as PPA, frontal lobe dementia, ALS with P PA, and corticonigral and corticobasal ganglionic degenerations. Expand
The neuropsychological pattern of corticobasal degeneration
TLDR
Patients with CBD show a specific neuropsychological pattern associating a dysexecutive syndrome, likely due to degeneration of the basal ganglia and prefrontal cortex, and asymmetric praxis disorders, which might be related to premotor and parietal lobe lesions. Expand
...
1
2
3
4
5
...